Skip to content

Sands Capital Alternatives, LLC

Follow

13F filer, CIK 1846444, ARLINGTON, VA

Sands Capital Alternatives, LLC reported $694,687,815 across 24 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-13. Its ten largest share positions make up 81.33% of the portfolio.

Accepted , ingested 13F-HR 0001846444-26-000013

Period
2026-09-30
Reported value
$695M
Holdings
24
Top 10 weight
81.33%
New
1
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
FRNMnew+1,201,998$18.9M
CBRSadded+89,659$15.9M
BBNXadded+289,855$5.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
DDOGreduced-17,831-$4.88M
IOTreduced-120,037-$4.58M
DASHreduced-20,261-$3.72M
KVYOreduced-100,787-$1.59M
TOSTreduced-49,972-$1.45M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001846444-26-000013, largest first. % of portfolio is the value over $694,687,815, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ALMRALAMAR BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 4,230,926 shares; 2026Q3: 4,230,926 shares 4,230,926$144M20.75%0Timeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,021,159 shares; 2025Q1: 7,164,355 shares; 2025Q2: 7,175,434 shares; 2025Q3: 7,175,434 shares; 2025Q4: 6,861,399 shares; 2026Q1: 6,537,769 shares; 2026Q2: 7,094,952 shares; 2026Q3: 6,991,934 shares 6,991,934$88.5M12.74%-103,018Timeline
BBNXBETA BIONICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,103,782 shares; 2025Q2: 3,570,113 shares; 2025Q3: 3,570,113 shares; 2025Q4: 3,570,113 shares; 2026Q1: 3,708,043 shares; 2026Q2: 3,708,043 shares; 2026Q3: 3,997,898 shares 3,997,898$75.9M10.92%+289,855Timeline
SGPSPYGLASS PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,500,012 shares; 2026Q2: 2,500,012 shares; 2026Q3: 2,500,012 shares 2,500,012$65M9.36%0Timeline
KVYOKLAVIYO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,470,694 shares; 2025Q1: 3,443,515 shares; 2025Q2: 3,515,065 shares; 2025Q3: 3,515,065 shares; 2025Q4: 3,649,678 shares; 2026Q1: 3,649,678 shares; 2026Q2: 3,928,146 shares; 2026Q3: 3,827,359 shares 3,827,359$60.2M8.67%-100,787Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 481,770 shares; 2025Q1: 481,770 shares; 2025Q2: 481,770 shares; 2025Q3: 481,770 shares; 2025Q4: 481,770 shares; 2026Q1: 481,770 shares; 2026Q2: 481,770 shares; 2026Q3: 481,770 shares 481,770$43.5M6.27%0Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,950,000 shares; 2025Q1: 10,950,000 shares; 2025Q2: 10,950,000 shares; 2025Q3: 10,950,000 shares; 2025Q4: 13,018,965 shares; 2026Q1: 13,018,965 shares; 2026Q2: 13,018,965 shares; 2026Q3: 13,018,965 shares 13,018,965$26.8M3.86%0Timeline
CBRSCEREBRAS SYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,825 shares; 2026Q3: 122,484 shares 122,484$21.8M3.13%+89,659Timeline
DASHDOORDASH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 407,343 shares; 2025Q1: 380,704 shares; 2025Q2: 381,202 shares; 2025Q3: 90,142 shares; 2025Q4: 95,618 shares; 2026Q1: 111,231 shares; 2026Q2: 127,562 shares; 2026Q3: 107,301 shares 107,301$19.7M2.84%-20,261Timeline
ODTXODYSSEY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 875,000 shares; 2026Q3: 875,000 shares 875,000$19.4M2.8%0Timeline
FRNMFREENOME INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,201,998 shares 1,201,998$18.9M2.73%newTimeline
CPNGCOUPANG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 924,712 shares; 2025Q1: 843,476 shares; 2025Q2: 849,031 shares; 2025Q3: 795,006 shares; 2025Q4: 870,424 shares; 2026Q1: 1,012,091 shares; 2026Q2: 1,329,314 shares; 2026Q3: 1,244,409 shares 1,244,409$17.3M2.48%-84,905Timeline
DDOGDATADOG INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 97,788 shares; 2025Q1: 117,930 shares; 2025Q2: 118,707 shares; 2025Q3: 118,707 shares; 2025Q4: 85,793 shares; 2026Q1: 85,793 shares; 2026Q2: 80,851 shares; 2026Q3: 63,020 shares 63,020$17.3M2.48%-17,831Timeline
IOTSAMSARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 198,690 shares; 2025Q1: 253,432 shares; 2025Q2: 438,485 shares; 2025Q3: 598,914 shares; 2025Q4: 466,190 shares; 2026Q1: 560,287 shares; 2026Q2: 515,658 shares; 2026Q3: 395,621 shares 395,621$15.1M2.17%-120,037Timeline
TOSTTOAST INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 231,530 shares; 2025Q1: 210,611 shares; 2025Q2: 156,604 shares; 2025Q3: 156,604 shares; 2025Q4: 301,647 shares; 2026Q1: 301,647 shares; 2026Q2: 364,879 shares; 2026Q3: 314,907 shares 314,907$9.13M1.31%-49,972Timeline
ABOSACUMEN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,417,075 shares; 2025Q1: 3,417,075 shares; 2025Q2: 3,417,075 shares; 2025Q3: 3,417,075 shares; 2025Q4: 3,417,075 shares; 2026Q1: 3,720,105 shares; 2026Q2: 3,720,105 shares; 2026Q3: 3,720,105 shares 3,720,105$8.26M1.19%0Timeline
SNOWSNOWFLAKE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 39,007 shares; 2025Q1: 26,828 shares; 2025Q2: 27,005 shares; 2025Q3: 27,005 shares; 2025Q4: 20,253 shares; 2026Q1: 20,253 shares; 2026Q2: 24,498 shares; 2026Q3: 22,926 shares 22,926$7.78M1.12%-1,572Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 170,000 shares; 2025Q1: 170,000 shares; 2025Q2: 170,000 shares; 2025Q3: 170,000 shares; 2025Q4: 85,000 shares; 2026Q1: 85,000 shares; 2026Q2: 85,000 shares; 2026Q3: 85,000 shares 85,000$6.68M0.96%0Timeline
TTANSERVICETITAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 89,856 shares; 2026Q1: 89,856 shares; 2026Q2: 108,545 shares; 2026Q3: 91,101 shares 91,101$5.99M0.86%-17,444Timeline
BIOABIOAGE LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 786,353 shares; 2025Q1: 786,353 shares; 2025Q2: 786,353 shares; 2025Q3: 786,353 shares; 2025Q4: 786,353 shares; 2026Q1: 786,353 shares; 2026Q2: 786,353 shares; 2026Q3: 786,353 shares 786,353$5.58M0.8%0Timeline
MNDYMONDAY COM LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 48,278 shares; 2025Q1: 49,908 shares; 2025Q2: 58,336 shares; 2025Q3: 58,336 shares; 2025Q4: 67,868 shares; 2026Q1: 67,868 shares; 2026Q2: 81,982 shares; 2026Q3: 67,182 shares 67,182$5.27M0.76%-14,800Timeline
ACRVACRIVON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,122,605 shares; 2025Q1: 2,122,605 shares; 2025Q2: 2,122,605 shares; 2025Q3: 2,122,605 shares; 2025Q4: 2,122,605 shares; 2026Q1: 2,122,605 shares; 2026Q2: 2,289,271 shares; 2026Q3: 2,289,271 shares 2,289,271$4.69M0.68%0Timeline
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 405,837 shares; 2025Q1: 405,837 shares; 2025Q2: 405,837 shares; 2025Q3: 405,837 shares; 2025Q4: 405,837 shares; 2026Q1: 405,837 shares; 2026Q2: 405,837 shares; 2026Q3: 405,837 shares 405,837$4.24M0.61%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 724,873 shares; 2025Q1: 724,873 shares; 2025Q2: 724,873 shares; 2025Q3: 724,873 shares; 2025Q4: 724,873 shares; 2026Q1: 724,873 shares; 2026Q2: 724,873 shares; 2026Q3: 724,873 shares 724,873$3.53M0.51%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FIGFIGMA INC22,165$401Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001846444-26-000013 base2026-11-13